Volume 3, Issue 1 (2-2019)                   GMJ Medicine 2019, 3(1): 105-117 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheykhi M T. Aging vs Alzheimer's Disorders and Medicaments in Developing World. GMJ Medicine. 2019; 3 (1) :105-117
URL: http://gmjpress.de/article-1-49-en.html
Professor Emeritus of Sociology, Alzahra University, Tehran, Iran
Abstract:   (344 Views)
The present article exposes the relationship between aging and facing Alzheimer's disorders within increasing number of people with special reference to the developing countries. In modern times, many developing countries are benefited of more access to hygiene, medicine, education, communications, social networks, and the like. All such factors have determining roles in people's aging and life expectancy. For example, many Asian countries have doubled or tripled the number of their elderly citizens between 1995 and 2015. Therefore, aging is undoubtedly increasing, while medicaments and geriatrics are not increasing at the same rate-leaving behind increasing Alzheimer's disorders. Trouble is even much more over the age of 65, when one of the two (couple) is dead, and remaining person must self-control oneself. So, what the developing countries need to do, is to further invest on medicaments and geriatrics for the people heading to the age 65 and beyond. It must be accepted as a gerontological fact that aging is ever enlarging and extending-needing further means to put up with that.
Full-Text [PDF 446 kb]   (149 Downloads)    
Type of Study: Original Article | Subject: Brain Disorders
Received: 2019/04/20 | Accepted: 2019/05/30 | Published: 2019/06/15

Add your comments about this article : Your username or Email:
CAPTCHA

© 2019 All Rights Reserved | GMJ Medicine